Regulations.gov document
Advisory Committee; Bone, Reproductive and Urologic Drugs Advisory Committee; Change of…
Rule · FDA-2019-N-4203 · posted Mar 23, 2022
Key facts
| Document ID | FDA-2019-N-4203-0034 |
|---|---|
| Title | Advisory Committee; Bone, Reproductive and Urologic Drugs Advisory Committee; Change of Name and Function; Technical Amendment |
| Document type | Rule |
| Subtype | Final Rule |
| Agency | FDA |
| Docket | FDA-2019-N-4203 |
| Posted | Mar 23, 2022 |
| Federal Register citation | 87 FR 16393 |
| FR document number | 2022-05965 |
| CFR | 21 CFR Part 14 |
| Comment period opens | Mar 23, 2022 |
| Effective date | Mar 23, 2022 |
At a glance
- 1–9 Pages
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: